Article
Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.
Endocrine-related cancer - 1 Oct 2016
Milne Roger L, Antoniou Antonis C
Abstract excerpt
Pathogenic mutations in BRCA1 and BRCA2 are associated with high risks of breast and ovarian cancer. However, penetrance estimates for mutation carriers have been found to vary substantially between studies, and the observed differences in risk are consistent with the hypothesis that genetic and environmental factors modify cancer risks for women with these mutations. Direct evidence that this is the case has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
